| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President, Head Of R&D | Chief Executive Officer
4 companies
Morrison Briggs is a Director at ARVINAS, INC. with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 14 sells.
Estimated insider holdings value: $1.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | ARVN Arvinas, Inc. | Director | Buy | 30,000 | $7.57 | $227,010.00 | +65.2% | +63.6% | - | |
| Aug 9, 2023 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 52,855 | $18.27 | $965,401.86 | -74.8% | -21.7% | +7.1% | |
| Jul 10, 2023 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 52,855 | $20.40 | $1,078,067.58 | -74.8% | -38.4% | +11.3% | |
| Jun 9, 2023 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 52,855 | $21.18 | $1,119,421.33 | -45.3% | -14.7% | -7.8% | |
| May 9, 2023 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 52,855 | $21.41 | $1,131,477.56 | -74.8% | -14.5% | +3.5% | |
| Apr 10, 2023 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 52,855 | $19.53 | $1,032,237.01 | -74.8% | +4.8% | +18.9% | |
| Mar 13, 2023 | SNDX Syndax Pharmaceuticals Inc | President, Head Of R&D | Sale+OE | 52,854 | $22.53 | $1,190,673.77 | -74.8% | -7.5% | +6.4% | |
| Feb 6, 2023 | SNDX Syndax Pharmaceuticals Inc | President, Head Of R&D | Sale+OE | 52,854 | $26.83 | $1,417,908.97 | -74.8% | -23.5% | -14.7% | |
| Sep 20, 2022 | SNDX Syndax Pharmaceuticals Inc | President, Head Of R&D | Sale+OE | 173,988 | $23.11 | $4,020,056.46 | -83.0% | -1.2% | -31.1% | |
| Sep 16, 2022 | SNDX Syndax Pharmaceuticals Inc | President, Head Of R&D | Sale+OE | 279,420 | $23.64 | $6,604,327.22 | -79.7% | +4.6% | -25.0% |